The United Laboratories International Holdings Limited 3933.HK

Healthcare · Drug Manufacturers - Specialty & Generic · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$5.03B
Market Cap
$1.92B
Margin of Safety
61.9%
Intrinsic / Market Ratio
2.62

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

7.36B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

5.23B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

2.50B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

5.03B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

5.03B USD

from the sum above

Market Cap

1.92B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

2.62×

the ratio the screener ranks by; Margin of Safety +61.9% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 7.36B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)6.56B USD
+②Net Cash Today803.35M USD
+③Growth Value0 USD
=Value7.36B USD

EPV of the Operations (NOPAT over WACC)

6.56B USD

Net cash today

+803.35M USD

Growth Value

0 USD

Value

7.36B USD

①EPV (earnings power value)

6.56B USD

②Net Cash Today

803.35M USD

③Growth Value

0 USD

Market value

Market Cap1.92B USD

Today's price times the shares.

Value vs market

Margin of Safety+74.0%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 5.23B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE2.74B USD
+②Equity at Year 15, Today2.48B USD
=Value5.23B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

2.74B USD

②Equity at Year 15, Today

2.48B USD

Market value

Market Cap1.92B USD

Today's price times the shares.

Value vs market

Margin of Safety+63.3%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 2.50B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 2.50B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap1.92B USD

Today's price times the shares.

Value vs market

Margin of Safety+23.3%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 4.87%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.29×Market Risk Premium 6.00%= 6.26%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 63.94M USDPretax Income 361.70M USD= 17.68%

The tax the interest saves.

Interest Expense =EBIT 371.68M USD−Pretax Income 361.70M USD= 9.98M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 9.98M USDTotal Debt 714.21M USD×(1 − Tax Rate for WACC 17.68%)= 1.15%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 714.21M USDMarket Cap + Total Debt 1.92B USD + 714.21M USD= 27.14%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 72.86%×Cost of Equity 6.26%+Debt Weight 27.14%×Cost of Debt 1.15%= 4.87%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2025-12-31.

Total Assets 4.42B USD − Total Liabilities 1.92B USD = Book Value Today 2.50B USD

Total Debt 714.21M USD − Cash and Short-Term Investments 1.52B USD = Net Debt Today -803.35M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 18.6%at most 5%does not pass1,973,026,508 / 1,817,026,508
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets5.4%at least -10.0%passes(536.52M USD − 298.45M USD) ÷ 4.42B USD
Price to bookMarket Cap ÷ Book Value Today0.77×at most 3×passes1.92B USD ÷ 2.50B USD
Operating marginOperating Income ÷ Revenue18.8%above 10.0%passes355.39M USD ÷ 1.89B USD
Revenue growthRevenue ÷ Revenue a Year Before − 10.2%above 10.0%does not pass1.89B USD / 1.89B USD
Net cash(Cash − Total Debt) ÷ Market Cap41.9%above -30%passes(1.52B USD − 714.21M USD) ÷ 1.92B USD
Operating efficiencyOperating Income ÷ Gross Profit45.0%above 25.0%passes355.39M USD ÷ 788.95M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

8 USD

Enterprise value

9.99B USD

market cap plus net debt

EV / EBITDA

8.08×

Price / book

0.75×

the provider's book

Price / earnings

27.23×

Return on equity

3.2%

the provider's, not the engine's

Profit margin

4.5%

Revenue growth

-18.0%

Analyst target, mean

13 USD

Analysts

8

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

1.63B1.94B1.89B1.89B

Gross profit

714.33M892.24M834.25M788.95M

Operating income

300.65M463.29M427.43M355.39M

EBITDA

operating income before depreciation and amortisation

379.63M560.11M540.32M464.61M

Pretax income

288.49M471.01M451.10M361.70M

Net income

227.29M380.48M364.80M298.45M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

229.34M378.63M355.26M278.99M

R&D

85.33M106.66M122.18M131.78M
Balance sheet, year end

Total assets

2.73B2.96B3.54B4.42B

Total liabilities

1.20B1.16B1.56B1.92B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

1.52B1.79B1.97B2.49B

Total debt

354.04M211.79M432.84M714.21M

Cash and equivalents

681.85M600.29M868.19M1.52B

Net PP&E

fixed assets after depreciation

900.84M986.55M1.30B1.73B

Working capital

current assets less current liabilities

788.07M1.01B1.00B1.20B
Cash flow

Operating cash flow

291.91M343.59M438.81M536.52M

Capital expenditure

paid out, so below zero

-117.66M-205.91M-256.53M-414.13M

Depreciation and amortisation

79.42M79.67M84.43M92.94M

Free cash flow

operating cash flow plus capital expenditure

174.25M137.68M182.29M122.40M